| CSPYX | VRTIX | CSPYX / VRTIX | |
| Total Expense Ratio | 0.20 | 0.07 | 286% |
| Annual Report Gross Expense Ratio | 0.20 | 0.07 | 286% |
| Fund Existence | 9 years | 15 years | - |
| Gain YTD | 5.828 | 6.855 | 85% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 5000000 | 20% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.56B | 14.3B | 18% |
| Annual Yield % from dividends | 1.27 | 1.25 | 101% |
| Returns for 1 year | 0.44 | 19.93 | 2% |
| Returns for 3 years | -1.49 | 42.44 | -4% |
| Returns for 5 years | -12.50 | 27.09 | -46% |
| Returns for 10 years | N/A | 175.04 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNCX | 68.83 | 0.79 | +1.16% |
| Janus Henderson Global Life Sciences C | |||
| NPSGX | 19.86 | 0.10 | +0.51% |
| Nicholas Partners Small Cap Gr Instl | |||
| SSRRX | 6.90 | 0.01 | +0.15% |
| Touchstone Small Company R6 | |||
| CMRGX | 10.22 | 0.01 | +0.10% |
| Calamos Merger Arbitrage I | |||
| MAGCX | 30.95 | -0.03 | -0.10% |
| BlackRock Advantage Global Institutional | |||